2 weeks Ago By ABMN Staff
AdaptHealth Corp. ( NASDAQ:AHCO – Get Free Report ) was the recipient of a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 8,960,000 shares, a growth of 12.
0% from the August 31st total of 8,000,000 shares. Currently, 10.8% of the company’s stock are short sold.
Based on an average daily volume of 1,210,000 shares, the days-to-cover ratio is currently 7.4 days. Insiders Place Their Bets In related news, COO Shaw Rietkerk sold 25,000 shares of the firm’s stock in a transaction dated Friday, September 20th.
The shares were sold at an average price of $11.24, for a total value of $281,000.00.
Following the completion of the sale, the chief operating officer now directly owns 212,611 shares in the company, valued at approximately $2,389,747.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website .
In related news, Director David Solomon Williams III sold 4,000 shares of the business’s stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $11.26, for a total value of $45,040.
00. Following the completion of the sale, the director now directly owns 36,899 shares in the company, valued at approximately $415,482.74.
The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website . Also, COO Shaw Rietkerk sold 25,000 shares of AdaptHealth stock in a transaction on Friday, September 20th. The stock was sold at an average price of $11.
24, for a total value of $281,000.00. Following the sale, the chief operating officer now directly owns 212,611 shares of the company’s stock, valued at approximately $2,389,747.
64. The disclosure for this sale can be found here . Insiders own 4.
43% of the company’s stock. Institutional Trading of AdaptHealth A number of hedge funds and other institutional investors have recently modified their holdings of AHCO. Mackenzie Financial Corp grew its position in AdaptHealth by 48.
6% during the 2nd quarter. Mackenzie Financial Corp now owns 34,489 shares of the company’s stock worth $345,000 after acquiring an additional 11,280 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in AdaptHealth by 8.
1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 39,440 shares of the company’s stock valued at $394,000 after buying an additional 2,959 shares during the last quarter. MBB Public Markets I LLC acquired a new stake in AdaptHealth during the 2nd quarter worth approximately $142,000.
Dark Forest Capital Management LP bought a new stake in AdaptHealth during the 2nd quarter worth approximately $384,000. Finally, Caxton Associates LP bought a new position in shares of AdaptHealth during the second quarter valued at $383,000. Institutional investors own 82.
67% of the company’s stock. AdaptHealth Stock Up 8.1 % AdaptHealth ( NASDAQ:AHCO – Get Free Report ) last posted its earnings results on Tuesday, August 6th.
The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.
06). The company had revenue of $805.98 million during the quarter, compared to the consensus estimate of $802.
62 million. AdaptHealth had a positive return on equity of 9.58% and a negative net margin of 21.
20%. The firm’s revenue was up 1.6% compared to the same quarter last year.
During the same period last year, the company posted $0.16 EPS. Equities analysts expect that AdaptHealth will post 0.
87 earnings per share for the current fiscal year. Analyst Upgrades and Downgrades Separately, Royal Bank of Canada reissued an “outperform” rating and issued a $13.00 price objective on shares of AdaptHealth in a report on Monday, August 12th.
One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $10.
70. Get Our Latest Stock Report on AdaptHealth AdaptHealth Company Profile ( Get Free Report ) AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States.
The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. Read More Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter .
.
